Association between Mycoplasma pneumoniae infection and adverse pregnancy outcome: a propensity score weighting study
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1663272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Caihua Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Pregnancy Outcome, Pneumonia, Mycoplasma, Pregnancy Complications, Infectious. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
After COVID-19 pandemic, there has been an upward trend in Mycoplasma pneumoniae ( M. pneumoniae ) infections across Asia. The COVID-19-induced immunological impairment may increase the risk of adverse outcomes in M. pneumoniae -infected patients, yet studies in this area remain limited. We investigated the association between M. pneumoniae infection and adverse pregnancy outcomes in the post-COVID-19 era.
Methods
We conducted a single-center cohort study in Guangzhou, China, from February 2023 to June 2024, involving pregnant women. A total of 186 participants were included, with 49 in the M. pneumoniae group (tested positive for M. pneumoniae immunoglobulin M antibody (MP IgM)) and 137 in the control group. Propensity score weighting analysis was performed to control bias and estimate the effect size.
Results
The incidence of adverse pregnancy outcomes in the M. pneumoniae group was not significantly different from that in the control group. The odds ratio (OR) for adverse maternal events after propensity score weighting (PSW) was 1.25 (95% confidence interval [CI], 0.62 to 2.55; p = 0.530), and the PSW OR for adverse neonatal events was 0.95 (95% CI, 0.49 to 1.84; p = 0.884). However, in the subgroups of advanced maternal age (AMA, age ≥ 35, n=29) and primiparous women (n=80), the incidence of adverse pregnancy outcomes was significantly higher in the M. pneumoniae group. Additionally, the clinical manifestations of M. pneumoniae infection in the post-COVID-19 era were consistent with those observed prior to the pandemic.
Conclusions
In the post-COVID-19 era, evidence remains insufficient to conclude that M. pneumoniae infection increases the risk of adverse pregnancy outcomes in the general pregnant population. Exploratory subgroup analyses suggest possible signals of risk within subgroups of AMA and primiparous women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- School of Biomedical Engineering, Hainan University, Sanya, China.
- Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China.
- Hainan Lecheng Institute of Real World Study, The Administration of Boao Lecheng International Medical Tourism Pilot Zone, Hainan, Qionghai, China.
Zitieren
APA
Yang, C., Jiang, H., Li, L., Zheng, P., Li, Y., & Wu, Y. (2025). Association between Mycoplasma pneumoniae infection and adverse pregnancy outcome: a propensity score weighting study. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1663272
Vancouver
Yang C, Jiang H, Li L, Zheng P, Li Y, Wu Y. Association between Mycoplasma pneumoniae infection and adverse pregnancy outcome: a propensity score weighting study. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1663272
BibTeX
@article{Yang2025,
author = {Yang, Caihua and Jiang, Haoxuan and Li, Linyan and Zheng, Ping and Li, Yilei and Wu, Ying},
title = {Association between Mycoplasma pneumoniae infection and adverse pregnancy outcome: a propensity score weighting study},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1663272}
}
EUVIMED